Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Next-Generation Targeted Therapy: The Evolving Role of Taletrectinib in Fusion-Positive Malignancies.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Published: December 09, 2025
Targeting ROS1 in NSCLC: Clinical Advances and Future Directions of Taletrectinib.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Published: November 03, 2025
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; durvalumab, cemiplimab, zongertinib, and taletrectinib for lung cancer, pirtobrutinib and atezolizumab for lymphoma, durvalumab for bladder cancer, panitumumab plus sotorasib for colorectal cancer, and vorasidenib for glioma.
Journal: International journal of clinical oncology
Published: October 25, 2025
Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.
Journal: Current oncology (Toronto, Ont.)
Published: October 15, 2025
Taletrectinib in ROS1-positive NSCLC: bridging clinical trials and real-world practice.
Journal: Annals of medicine and surgery (2012)
Published: September 09, 2025
Taletrectinib in ROS1 Fusion-Positive Non-Small Cell Lung Cancer: Promising Yet Premature?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 21, 2025
Reply to: "Baseline Brain Metastasis Imbalance in TRUST: Implications for Interpreting Intracranial Efficacy of Taletrectinib" and "Taletrectinib in ROS1 Fusion-Positive Non-Small Cell Lung Cancer: Promising Yet Premature?"
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 21, 2025
Baseline Brain Metastasis Imbalance in TRUST: Implications for Interpreting Intracranial Efficacy of Taletrectinib.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 21, 2025
Taletrectinib Adipate.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: August 12, 2025
Taletrectinib (Ibtrozi) - another kinase inhibitor for non-small cell lung cancer (NSCLC).
Journal: The Medical letter on drugs and therapeutics
Published: July 29, 2025
Toxicity profiles of ROS1 tyrosine kinase inhibitors in advanced non-small cell lung cancer: a systematic review and proportional meta-analysis.
Journal: Frontiers in pharmacology
Published: June 09, 2025
Last Updated: 01/07/2026